Lidia Ciołek

Mrs. Lidia Ciołek


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2022 in Polymers
Verified
Journal Article
Open access
PDF file
MCMilena Chraniuk
Milena Chraniuk
MPMirosława Panasiuk
Mirosława Panasiuk
Lilit HovhannisyanLilit Hovhannisyan
Lilit Hovhannisyan
SNSabina Nidzworska
Sabina Nidzworska
DNDawid Nidzworski
Dawid Nidzworski
Beata GromadzkaBeata Gromadzka
Beata Gromadzka
Background: Cytotoxicity testing is a primary method to establish the safety of biomaterials, e.g., biocomposites. Biomaterials involve a wide range of medical materials, which are usually solid materials and are used in bone regeneration, cardiology, or dermatology. Current advancements in science and technology provide several standard cytotoxicity testing methods that are sufficiently sensitive to detect various levels of cellular toxicity, i.e., from low to high. The aim was to compare the direct and indirect methodology described in the ISO guidelines UNE-EN ISO 10993-5:2009 Part 5. Methods: Cell proliferation was measured using WST-1 assay, and cytotoxicity was measured using LDH test kit. Results: The results indicate that the molecular surface of biomaterials have impact on the cytotoxicity and proliferation profile. Based on these results, we confirm that the indirect method does not provide a clear picture of the cell condition after the exposure to the surface, and moreover, cannot provide complete results about the effects of the material. Conclusions: Comparison of both methods shows that it is pivotal to investigate biomaterials at the very early stages using both indirect and direct methods to access the influence of the released toxins and surface of the material on the cell condition.

24 November 2018 in International Journal of Applied Ceramic Technology
Verified
Journal Article
Closed access
PDF file
LCLidia Ciołek
Lidia Ciołek
MBMonika Biernat
Monika Biernat
ZJZbigniew Jaegermann
Zbigniew Jaegermann
EZEwa Zaczyńska
Ewa Zaczyńska
ACAnna Czarny
Anna Czarny
AOAndrzej Olszyna
Andrzej Olszyna

29 May 2023 in Polymers
Verified
Journal Article
Open access
PDF file
MBMonika Biernat
Monika Biernat
ASAnna Wanda Sylla
Anna Wanda Sylla
MCMilena Chraniuk
Milena Chraniuk
MPMirosława Panasiuk
Mirosława Panasiuk
PTPaulina Tymowicz-Grzyb
Paulina Tymowicz-Grzyb
ZJZbigniew Jaegermann
Zbigniew Jaegermann
Chitosan is one of the most commonly employed natural polymers for biomedical applications. However, in order to obtain stable chitosan biomaterials with appropriate strength properties, it is necessary to subject it to crosslinking or stabilization. Composites based on chitosan and bioglass were prepared using the lyophilization method. In the experimental design, six different methods were used to obtain stable, porous chitosan/bioglass biocomposite materials. This study compared the crosslinking/stabilization of chitosan/bioglass composites with ethanol, thermal dehydration, sodium tripolyphosphate, vanillin, genipin, and sodium β-glycerophosphate. The physicochemical, mechanical, and biological properties of the obtained materials were compared. The results showed that all the selected crosslinking methods allow the production of stable, non-cytotoxic porous composites of chitosan/bioglass. The composite with genipin stood out with the best of the compared properties, taking into account biological and mechanical characteristics. The composite stabilized with ethanol is distinct in terms of its thermal properties and swelling stability, and it also promotes cell proliferation. Regarding the specific surface area, the highest value exposes the composite stabilized by the thermal dehydration method.

14 August 2020 in International Journal of Applied Ceramic Technology
Verified
Journal Article
Closed access
PDF file
MBMonika Biernat
Monika Biernat
LCLidia Ciołek
Lidia Ciołek
MDMaria Dzierzynska
Maria Dzierzynska
AOArtur Oziębło
Artur Oziębło
JSJustyna Sawicka
Justyna Sawicka
SRSylwia Rodziewicz‐Motowidło
Sylwia Rodziewicz‐Motowidło

10 July 2017 in International Journal of Applied Ceramic Technology
Verified
Journal Article
Closed access
PDF file
LCLidia Ciołek
Lidia Ciołek
MBMonika Biernat
Monika Biernat
ZJZbigniew Jaegermann
Zbigniew Jaegermann
PTPaulina Tymowicz‐Grzyb
Paulina Tymowicz‐Grzyb
PTPiotr Taźbierski
Piotr Taźbierski
AOAndrzej Olszyna
Andrzej Olszyna

4 October 2023 in Polymers
Verified
Journal Article
Open access
PDF file
LCLidia Ciołek
Lidia Ciołek
MKMałgorzata Krok-Borkowicz
Małgorzata Krok-Borkowicz
AGArkadiusz Gąsiński
Arkadiusz Gąsiński
MBMonika Biernat
Monika Biernat
AAAgnieszka Antosik
Agnieszka Antosik
Elżbieta PamułaElżbieta Pamuła
Elżbieta Pamuła
The development of innovative biomaterials with improved integration with bone tissue and stimulating regeneration processes is necessary. Here, we evaluate the usefulness of bioactive glasses from the SiO2-P2O5-CaO system enriched with 2 wt.% SrO or ZnO in the manufacturing of chitosan-based scaffolds. Bioglasses produced using the sol-gel method were subjected to thermal treatment in different regimes. Chitosan/bioglass composites were produced with a weight ratio. Bioglasses were evaluated via TG-DTA, FTIR, and SEM-EDS before and after incubation in simulated body fluid (SBF). The release of ions was tested. The cytocompatibility of the composites in contact with MG63 osteoblast-like cells was evaluated. The results showed that the presence of the crystalline phase decreased from 41.2–44.8% for nonmodified bioglasses to 24.2–24.3% for those modified with ZnO and 22.0–24.2% for those modified with SrO. The samples released Ca2+, Zn2+, and/or Sr2+ ions and were bioactive according to the SBF test. The highest cytocompatibility was observed for the composites containing nonmodified bioglasses, followed by those enriched with SrO bioglasses. The least cytocompatible were the composites containing ZnO bioglasses that released the highest amount of Zn2+ ions (0.58 ± 0.07 mL/g); however, those that released 0.38 ± 0.04 mL/g were characterised by acceptable cytocompatibility. The study confirmed that it is feasible to control the biological performance of chitosan/bioglass composites by adjusting the composition and heat treatment parameters of bioglasses.